Straumann Holding AG

SWX:STMN Stock Report

Market Cap: CHF 13.0b

Straumann Holding Valuation

Is STMN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of STMN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: STMN (CHF81.28) is trading below our estimate of future cash flow value (CHF124.22)

Significantly Below Future Cash Flow Value: STMN is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for STMN?

Key metric: As STMN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for STMN. This is calculated by dividing STMN's market cap by their current earnings.
What is STMN's PE Ratio?
PE Ratio36.3x
EarningsCHF 356.71m
Market CapCHF 12.96b

Price to Earnings Ratio vs Peers

How does STMN's PE Ratio compare to its peers?

The above table shows the PE ratio for STMN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average55.9x
SOON Sonova Holding
20.2x10.36%CHF 10.5b
MOVE Medacta Group
33.7x11.90%CHF 3.0b
MED Medartis Holding
114.7x40.45%CHF 957.3m
MEDX medmix
55x34.27%CHF 352.2m
STMN Straumann Holding
36.3x16.19%CHF 13.0b

Price-To-Earnings vs Peers: STMN is good value based on its Price-To-Earnings Ratio (36.3x) compared to the peer average (55.9x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does STMN's PE Ratio compare vs other companies in the European Medical Equipment Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
STMN 36.3xIndustry Avg. 23.0xNo. of Companies12PE01632486480+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: STMN is expensive based on its Price-To-Earnings Ratio (36.3x) compared to the European Medical Equipment industry average (23x).

Price to Earnings Ratio vs Fair Ratio

What is STMN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

STMN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio36.3x
Fair PE Ratio37.7x

Price-To-Earnings vs Fair Ratio: STMN is good value based on its Price-To-Earnings Ratio (36.3x) compared to the estimated Fair Price-To-Earnings Ratio (37.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst STMN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 81.28
CHF 105.82
+30.20%
12.90%CHF 123.00CHF 79.00n/a17
Mar ’27CHF 92.60
CHF 107.78
+16.39%
11.26%CHF 123.00CHF 79.00n/a18
Feb ’27CHF 93.10
CHF 110.94
+19.17%
14.03%CHF 145.00CHF 80.00n/a18
Jan ’27CHF 93.46
CHF 111.74
+19.56%
14.67%CHF 145.00CHF 80.00n/a19
Dec ’26CHF 93.00
CHF 112.43
+20.89%
16.33%CHF 145.00CHF 75.00n/a20
Nov ’26CHF 101.00
CHF 112.73
+11.61%
17.21%CHF 145.00CHF 75.00n/a20
Oct ’26CHF 85.86
CHF 116.70
+35.92%
16.15%CHF 150.00CHF 85.00n/a20
Sep ’26CHF 94.98
CHF 118.65
+24.92%
14.80%CHF 150.00CHF 85.00n/a20
Aug ’26CHF 99.14
CHF 125.00
+26.08%
15.38%CHF 150.00CHF 89.00n/a20
Jul ’26CHF 104.55
CHF 125.65
+20.18%
16.12%CHF 163.00CHF 89.00n/a20
Jun ’26CHF 105.55
CHF 126.71
+20.05%
15.93%CHF 163.00CHF 89.00n/a21
May ’26CHF 100.65
CHF 127.38
+26.56%
16.37%CHF 163.00CHF 89.00n/a21
Apr ’26CHF 106.70
CHF 135.55
+27.04%
15.23%CHF 163.00CHF 90.00n/a20
Mar ’26CHF 122.05
CHF 135.00
+10.61%
15.75%CHF 163.00CHF 90.00CHF 92.6019
Feb ’26CHF 130.35
CHF 132.05
+1.31%
16.84%CHF 175.00CHF 90.00CHF 93.1019
Jan ’26CHF 114.25
CHF 131.00
+14.66%
16.87%CHF 175.00CHF 90.00CHF 93.4618
Dec ’25CHF 114.65
CHF 131.12
+14.36%
17.32%CHF 175.00CHF 90.00CHF 93.0017
Nov ’25CHF 116.25
CHF 133.82
+15.12%
16.33%CHF 175.00CHF 90.00CHF 101.0017
Oct ’25CHF 137.75
CHF 137.06
-0.50%
16.38%CHF 175.00CHF 90.00CHF 85.8618
Sep ’25CHF 125.45
CHF 134.83
+7.48%
16.87%CHF 175.00CHF 90.00CHF 94.9818
Aug ’25CHF 113.45
CHF 134.33
+18.41%
18.13%CHF 175.00CHF 90.00CHF 99.1418
Jul ’25CHF 112.70
CHF 134.39
+19.24%
18.42%CHF 175.00CHF 90.00CHF 104.5518
Jun ’25CHF 117.00
CHF 135.94
+16.19%
18.16%CHF 175.00CHF 90.00CHF 105.5518
May ’25CHF 123.00
CHF 138.67
+12.74%
18.45%CHF 175.00CHF 90.00CHF 100.6518
Apr ’25CHF 144.00
CHF 142.32
-1.17%
18.38%CHF 175.00CHF 90.00CHF 106.7019
Mar ’25CHF 142.75
CHF 134.22
-5.97%
17.69%CHF 168.00CHF 90.00CHF 122.0518
CHF 105.82
Fair Value
23.2% undervalued intrinsic discount
17
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/30 12:50
End of Day Share Price 2026/03/30 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Straumann Holding AG is covered by 34 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert BateBarclays
Hassan Al-WakeelBarclays
Victoria LambertBerenberg